ALAMEDA Project at Frontiers Health 2023: advancing AI-driven healthcare for brain diseases
The ALAMEDA Project took part in the 2023 edition of Frontiers Health 2023 as a Silver Sponsor, bringing its vision for the future of digital and personalised healthcare to one of Europe’s leading innovation conferences.
Held in Rome on November 8–9, the event gathered researchers, clinicians, technology companies, policymakers and healthcare innovators from around the world to discuss the evolving role of artificial intelligence, digital health solutions and patient-centred innovation in modern medicine.
Within this international context, the ALAMEDA Project presented a series of technological and scientific developments aimed at improving the monitoring, management and personalisation of care for people living with neurological and brain-related conditions, including Parkinson’s disease, Multiple Sclerosis and Stroke.
One of the key moments linked to the project’s participation was the ALAMEDA Final Dissemination Workshop, organised on November 10th. The workshop offered an opportunity to reflect on the project’s achievements and explore the future potential of AI-driven healthcare systems in neurology and chronic disease management. Discussions focused on how advanced digital tools, real-time monitoring and data-driven approaches can contribute to more personalised and preventive healthcare models.
Among the innovations showcased during Frontiers Health 2023 was the presentation of the ALAMEDA AI Toolkit Version 1.0, an open-source web hub developed to support the global healthcare research community. The platform was designed to facilitate the sharing of AI methodologies, algorithms and real-time data streams, promoting collaboration between researchers and accelerating the development of digital health applications for neurological diseases.
The project also demonstrated its broader technological ecosystem, combining wearable technologies, multi-sensor monitoring systems and digital data collection tools. These solutions are intended to support both patients and caregivers by enabling continuous monitoring of motor functions, physiological parameters and lifestyle-related information. By integrating data collected from different sources, the ecosystem aims to provide clinicians and researchers with more comprehensive insights into disease progression and patient wellbeing.
A central aspect of the ALAMEDA approach is the idea that artificial intelligence should not replace healthcare professionals, but rather enhance clinical decision-making through more accurate, timely and personalised information. The project therefore represents an important example of how emerging technologies can contribute to building more connected, predictive and patient-centred healthcare systems across Europe.
The participation at Frontiers Health 2023 also reinforced the project’s commitment to collaboration, openness and scientific dissemination, helping position ALAMEDA within the broader European conversation on the future of digital health and AI in medicine.